Clinical Case Reports (Nov 2021)
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
- Sewanti Limaye,
- Darshana Patil,
- Dadasaheb Akolkar,
- Navin Srivastava,
- Revati Patil,
- Sachin Apurwa,
- Sanket Patil,
- Jinumary John,
- Rahul Gosavi,
- Prabhu Nesargikar,
- Prashant Kumar,
- Vineet Datta,
- Chirantan Bose,
- Zarrine Raazi,
- Ajay Srinivasan,
- Rajan Datar
Affiliations
- Sewanti Limaye
- Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute Mumbai Maharashtra India
- Darshana Patil
- Datar Cancer Genetics Nasik Maharashtra India
- Dadasaheb Akolkar
- Datar Cancer Genetics Nasik Maharashtra India
- Navin Srivastava
- Datar Cancer Genetics Nasik Maharashtra India
- Revati Patil
- Datar Cancer Genetics Nasik Maharashtra India
- Sachin Apurwa
- Datar Cancer Genetics Nasik Maharashtra India
- Sanket Patil
- Datar Cancer Genetics Nasik Maharashtra India
- Jinumary John
- Datar Cancer Genetics Nasik Maharashtra India
- Rahul Gosavi
- Datar Cancer Genetics Nasik Maharashtra India
- Prabhu Nesargikar
- HCG Cancer Centre Bengaluru Karnataka India
- Prashant Kumar
- Institute of Bioinformatics Bengaluru Karnataka India
- Vineet Datta
- Datar Cancer Genetics Nasik Maharashtra India
- Chirantan Bose
- Datar Cancer Genetics Nasik Maharashtra India
- Zarrine Raazi
- Datar Cancer Genetics Nasik Maharashtra India
- Ajay Srinivasan
- Datar Cancer Genetics Nasik Maharashtra India
- Rajan Datar
- Datar Cancer Genetics Nasik Maharashtra India
- DOI
- https://doi.org/10.1002/ccr3.4986
- Journal volume & issue
-
Vol. 9,
no. 11
pp. n/a – n/a
Abstract
Abstract Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers.
Keywords
- combination regimen
- encyclopedic tumor analysis
- gastric adenocarcinoma
- pazopanib
- personalized cancer treatment
- precision oncology
